CTRC
protein-codingchymotrypsin C
Gene summary
This gene encodes a member of the peptidase S1 family. The encoded protein is a serum calcium-decreasing factor that has chymotrypsin-like protease activity. Alternatively spliced transcript variants have been observed, but their full-length nature has not been determined. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~10.8 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0008185
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0008185
Submitter: Ambry Genetics
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CTRC variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_007272.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 2 | 217 | 2 | 222 | |
| missense | 8 | 417 | 24 | 1 | 450 | |
| nonsense | 3 | 6 | 2 | 11 | ||
| start loss | 2 | 2 | ||||
| frameshift | 3 | 8 | 3 | 14 | ||
| splice donor/acceptor (+/-2bp) | 5 | 6 | 11 | |||
| Total | 6 | 30 | 430 | 241 | 3 | 710 |
Highest pathogenic variant AF is 0.00029616486
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_009203.2 | 8 | MANE Select | |
| Ensembl | ENSP00000365116.4 | 8 | MANE Select | |
| Ensembl | ENSP00000365110.2 | 3 | Standard | |
| Ensembl | ENSP00000810611.1 | 8 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Cobalamin (Cbl, vitamin B12) transport and metabolism
- Metabolism
- Metabolism of water-soluble vitamins and cofactors
- Metabolism of vitamins and cofactors
- Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling
Biological Process
- proteolysis
- cobalamin metabolic process
Molecular Function
- serine-type endopeptidase activity
- protein binding
- peptidase activity
Cellular Component
- extracellular region
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000375949
- Coding exons
- 8
- Length
- 10803
- Individuals with no LoFs
- 125686
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 62
- Defined
- 125748
- p
- 0.000247
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.134 | 168 | 163 | 1.03 | 0.0000114 | 1740 |
| Missense (PolyPhen) | 74 | 68.744 | 1.0765 | 733 | ||
| Synonymous | -0.198 | 72 | 69.9 | 1.03 | 0.00000531 | 535 |
| Loss of Function | -0.521 | 17 | 14.8 | 1.15 | 7.38e-7 | 159 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00049 | 0.00049 | rare |
| Latino/Admixed American | 0.00052 | 0.00052 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00022 | 0.00022 | rare |
| Finnish | 0.000092 | 0.000092 | rare |
| European (Non-Finnish) | 0.00011 | 0.00011 | rare |
| South Asian | 0.00036 | 0.00036 | rare |
| Other | 0.0011 | 0.0011 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Regulates activation and degradation of trypsinogens and procarboxypeptidases by targeting specific cleavage sites within their zymogen precursors. Has chymotrypsin-type protease activity and hypocalcemic activity. {ECO:0000269|PubMed:23430245}.;
Intolerance Scores
- LoFtool
- 0.280
- RVIS EVS
- 0.02
- RVIS percentile EVS
- 55.22
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.271
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |